ZS Pharma

Topics • Pharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

AstraZeneca Seals Three Drug Deals

AstraZeneca to buy ZS Pharma for $2.7 billion

Top-Feature

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Aenova Holding GmbH

Aseptic processing by design: The flexible and efficient use of RABS and Isolators

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Predictive Simulation in Pharma Production

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Book

Innovation Management in Sustainable Chemistry

Innovation Management in Sustainable Chemistry

Comprehensive resource on sustainable chemistry, bridging the skill gap between academic science education and innovation and entrepreneurship